Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma
M Aggarwal, N Agrawal, N Yadav, P Verma… - Annals of …, 2018 - Springer
Autologous stem cell transplant (ASCT) is standard consolidation therapy in management of
multiple myeloma (MM) patients. We reviewed records of all consecutive MM patients who …
multiple myeloma (MM) patients. We reviewed records of all consecutive MM patients who …
High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome
L Kumar, D Ramavath, B Kataria, A Tiwari… - Indian Journal of …, 2019 - journals.lww.com
Methods: Between 1995 and 2016, 349 MM patients underwent ASCT. Patients' median age
was 52 yr, ranging from 29 to 68 yr, 68.2 per cent were males. Thirty three per cent patients …
was 52 yr, ranging from 29 to 68 yr, 68.2 per cent were males. Thirty three per cent patients …
Staging system to predict the risk of relapse in multiple myeloma patients undergoing autologous stem cell transplantation
Over the last decade autologous stem cell transplantation (ASCT) has emerged as the
standard of care in the management of Multiple Myeloma (MM). However, the cases of early …
standard of care in the management of Multiple Myeloma (MM). However, the cases of early …
Autologous stem cell transplantation for multiple myeloma in the novel agent era: Systematic review of Indian data and implications for resource constrained settings
Abstract Treatment of multiple myeloma has undergone significant advances in the last two
decades, leading to meaningful improvement in overall and progression free survival. The …
decades, leading to meaningful improvement in overall and progression free survival. The …
Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic …
A Arteche-López, A Kreutzman, A Alegre… - Bone Marrow …, 2017 - nature.com
The proportion of multiple myeloma patients in long-term complete response (LTCR-MM) for
more than 6 years after autologous stem cell transplantation (ASCT) is small. To evaluate …
more than 6 years after autologous stem cell transplantation (ASCT) is small. To evaluate …
Multiple myeloma with extramedullary disease: impact of autologous stem cell transplantation on outcome
Survival of patients with multiple myeloma (MM) has improved significantly during the past
15 years. This has been attributed to use of novel agents (for example, immune modulators …
15 years. This has been attributed to use of novel agents (for example, immune modulators …
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myeloma
Autologous hematopoietic cell transplantation (auto-HCT) using melphalan is the standard
of care in the management of myeloma. Auto-HCT is a safe procedure with tolerable toxicity …
of care in the management of myeloma. Auto-HCT is a safe procedure with tolerable toxicity …
Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?
G Barosi, RP Gale - Leukemia, 2019 - nature.com
Three randomized controlled trials and a meta-analysis reported lenalidomide given after
high-dose therapy and an autologous hemopoietic cell transplantation is associated with …
high-dose therapy and an autologous hemopoietic cell transplantation is associated with …
Correlation of microRNA 17-92 cluster host gene (MIR17HG) polymorphisms with susceptibility and prognosis for multiple myeloma
H Wu, T Huang, Z Ye, X Fu, K Hu, X Yang - Clinical Lymphoma Myeloma …, 2019 - Elsevier
Purpose To explore the correlation of MIR17HG polymorphism with susceptibility and
prognosis of multiple myeloma (MM). Patients and Methods A total of 217 MM patients …
prognosis of multiple myeloma (MM). Patients and Methods A total of 217 MM patients …
Clinical outcomes in multiple myeloma post-autologous transplantation—a single centre experience
U Kulkarni, AJ Devasia, A Korula, NA Fouzia… - Indian Journal of …, 2019 - Springer
There is paucity of data from developing countries on the clinical outcomes in myeloma post-
autologous transplantation. In this retrospective study, we used hospital records to retrieve …
autologous transplantation. In this retrospective study, we used hospital records to retrieve …